| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |